Apogee Historical Financial Ratios

APGE Stock   44.35  4.03  8.33%   
Apogee Therapeutics, is presently reporting on over 63 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.9 K or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Apogee Therapeutics, financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About Apogee Financial Ratios Analysis

Apogee Therapeutics,Financial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Apogee Therapeutics, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Apogee financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Apogee Therapeutics, history.

Apogee Therapeutics, Financial Ratios Chart

Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Apogee Therapeutics, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Apogee Therapeutics, sales, a figure that is much harder to manipulate than other Apogee Therapeutics, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Net Debt To E B I T D A

A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).

Return On Assets

A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.
Most ratios from Apogee Therapeutics,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Apogee Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
 2010 2023 2024 (projected)
Current Ratio15.2419.3813.85
Net Debt To EBITDA1.381.251.1

Apogee Therapeutics, fundamentals Correlations

-1.01.01.01.01.0-1.01.0-1.0-1.00.950.95-1.00.810.94-1.0-1.00.99-1.01.0-0.940.4-1.0-1.01.0-0.95
-1.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.96-0.951.0-0.83-0.951.01.0-0.991.0-1.00.93-0.421.01.0-1.00.94
1.0-1.01.01.01.0-1.01.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.01.0-0.930.42-1.0-1.01.0-0.94
1.0-1.01.01.01.0-1.01.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.01.0-0.930.42-1.0-1.01.0-0.94
1.0-1.01.01.01.0-1.01.0-1.0-1.00.950.95-1.00.810.94-1.0-1.00.99-1.01.0-0.940.4-1.0-1.01.0-0.95
1.0-1.01.01.01.0-1.01.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.01.0-0.930.42-1.0-1.01.0-0.94
-1.01.0-1.0-1.0-1.0-1.0-1.01.01.0-0.96-0.961.0-0.83-0.951.01.0-0.991.0-1.00.93-0.431.01.0-1.00.94
1.0-1.01.01.01.01.0-1.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.01.0-0.930.42-1.0-1.01.0-0.94
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.0-0.96-0.951.0-0.83-0.951.01.0-0.991.0-1.00.93-0.421.01.0-1.00.94
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.0-0.95-0.951.0-0.81-0.941.01.0-0.991.0-1.00.94-0.41.01.0-1.00.95
0.95-0.960.960.960.950.96-0.960.96-0.96-0.951.0-0.950.961.0-0.95-0.950.98-0.950.96-0.790.67-0.96-0.960.96-0.8
0.95-0.950.950.950.950.95-0.960.95-0.95-0.951.0-0.950.961.0-0.95-0.950.98-0.950.95-0.780.67-0.95-0.950.95-0.8
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.95-0.95-0.81-0.941.01.0-0.991.0-1.00.94-0.41.01.0-1.00.95
0.81-0.830.830.830.810.83-0.830.83-0.83-0.810.960.96-0.810.96-0.81-0.810.89-0.810.83-0.570.86-0.83-0.830.83-0.59
0.94-0.950.950.950.940.95-0.950.95-0.95-0.941.01.0-0.940.96-0.94-0.940.98-0.940.95-0.770.69-0.95-0.950.95-0.79
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.95-0.951.0-0.81-0.941.0-0.991.0-1.00.94-0.41.01.0-1.00.95
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.95-0.951.0-0.81-0.941.0-0.991.0-1.00.94-0.41.01.0-1.00.95
0.99-0.990.990.990.990.99-0.990.99-0.99-0.990.980.98-0.990.890.98-0.99-0.99-0.990.99-0.880.53-0.99-0.990.99-0.89
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.95-0.951.0-0.81-0.941.01.0-0.99-1.00.94-0.41.01.0-1.00.95
1.0-1.01.01.01.01.0-1.01.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.0-0.930.42-1.0-1.01.0-0.94
-0.940.93-0.93-0.93-0.94-0.930.93-0.930.930.94-0.79-0.780.94-0.57-0.770.940.94-0.880.94-0.93-0.070.930.93-0.931.0
0.4-0.420.420.420.40.42-0.430.42-0.42-0.40.670.67-0.40.860.69-0.4-0.40.53-0.40.42-0.07-0.42-0.420.42-0.09
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.96-0.951.0-0.83-0.951.01.0-0.991.0-1.00.93-0.421.0-1.00.94
-1.01.0-1.0-1.0-1.0-1.01.0-1.01.01.0-0.96-0.951.0-0.83-0.951.01.0-0.991.0-1.00.93-0.421.0-1.00.94
1.0-1.01.01.01.01.0-1.01.0-1.0-1.00.960.95-1.00.830.95-1.0-1.00.99-1.01.0-0.930.42-1.0-1.0-0.94
-0.950.94-0.94-0.94-0.95-0.940.94-0.940.940.95-0.8-0.80.95-0.59-0.790.950.95-0.890.95-0.941.0-0.090.940.94-0.94
Click cells to compare fundamentals

Apogee Therapeutics, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Apogee Therapeutics, is a strong investment it is important to analyze Apogee Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics,'s future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.43)
Return On Assets
(0.19)
Return On Equity
(0.26)
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.